Beatty P G
Bone Marrow Transplant Program, University of Utah School of Medicine, Salt Lake City 84132.
Transfus Sci. 1991;12(3):119-22. doi: 10.1016/0955-3886(91)90117-L.
Although marrow transplantation is the treatment of choice for chronic myelogenous leukemia, its full application is limited by donor availability. It now appears that the use of volunteer unrelated donors will be feasible and efficacious, albeit with a higher likelihood of complications. Thus, marrow grafting from unrelated donors should be considered in most instances where transplantation from a matched sibling would be contemplated.
尽管骨髓移植是慢性粒细胞白血病的首选治疗方法，但其全面应用受到供体可获得性的限制。现在看来，使用志愿非亲属供体将是可行且有效的，尽管并发症的可能性更高。因此，在大多数考虑进行同胞匹配移植的情况下，应考虑使用非亲属供体的骨髓移植。
